Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DAP000071

Drug Information
SynonymsDB00295; 4,5alpha-Epoxy-17-methyl-7-morphinen-3,6alpha-diol; MSIR; SDZ202-250; 47106-99-0; Infumorph; nchembio.64-comp1; 57-27-2; MORPHINE, (5A,6A)-7,8-DIDEHYDRO-4,5-EPOXY-17-METHYLMORPHINIAN-3,6-DIOL, MORPHIUM, MORPHIA, DOLCONTIN, DUROMORPH, MORPHINA, NEPENTHE; EINECS 200-320-2; Morphinan-3,6-alpha-diol, 7,8-didehydro-4,5-alpha-epoxy-17-methyl-; Morphine Extra-Forte; Duromorph; Oramorph SR; MolPort-003-849-273; Ms Emma; morphine; CHEMBL70; M-Eslon; Duramorph PF; MS/L; Morphin [German]; Hard stuff; Roxanol 100; (5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol; Dulcontin; 64-31-3; Astramorph PF; Roxanol; Morphine H.P; Morphin; Morphine Forte; M.O.S; Morphitec; Morphina [Italian]; Dolcontin; 85201-37-2; CCRIS 5762; Avinza; RMS Uniserts; UNII-76I7G6D29C; Morphium; Morfina; Unkie; Hocus; Morfina [Italian]; l-Morphine; 64-31-3 (sulfate (2:1) (salt) anhydrous); Morphina; nchembio.317-comp1; MS/S; Meconium; 6211-15-0 (sulfate (2:1) (salt) pentahydrate); LS-91748; 9H-9,9c-Iminoethanophenanthro(4,5-bcd)furan-3,5-diol, 4alpha,5,7alpha,8-tetrahydro-12-methyl-; Moscontin; 7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol; RMS; (5alpha,6alpha)-17-methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol; (-)(5.alpha.,6.alpha.)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol; 8053-16-5; (-)-Morphine; Rescudose; OMS Concentrate; C01516; Statex SR; Cube juice; Roxanol UD; CID5288826; SDZ 202-250; Ospalivina; 9H-9,9c-Iminoethanophenanthro(4,5-bcd)furan-3,5-diol, 4a,5,7a,8-tetrahydro-12-methyl-; 7,8-Didehydro-4,5-epoxy-17-methyl-morphinan-3,6-diol; Morphinism; Kadian; (7R,7AS,12BS)-3-METHYL-2,3,4,4A,7,7A-HEXAHYDRO-1H-4,12-METHANO[1]BENZOFURO[3,2-E]ISOQUINOLINE-7,9-DIOL; Dreamer; MORPHINE SULFATE; DEA No. 9300; 4-methyl-(13R,14S)-12-oxa-4-azapentacyclo[,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol; Nepenthe; Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl- (5alpha,6alpha)-; Epimorph; Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl-, (5alpha,6alpha)-; Morphia; BIDD:GT0147; HSDB 2134; (5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol; Morpho; 17-methyl-7,8-didehydro-4,5alpha-epoxymorphinan-3,6alpha-diol; Morphine [BAN]; MS Contin; CHEBI:17303; Statex Drops; (5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol; NSC11441; D-(-)-Morphine; Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl- (5..alpha.,6.alpha.)-; MOI; DepoDur; Morphinum; (-)Morphine sulfate    
Trade NameActiskenan; Algedol; Amidiaz; Analmorph; Anafil; Analfin; Anamorph; Astramorph; Avinza; Capros; Cloruro Morfico Braun; Compensan; Continue; Contalgin; DepoDur; Depolan; Dimorf; Dolcontin; Doloral; Doltard; Dulcontin; Duralgin; Duralmor; Duramorph; Embeda; Epidural; Epimorph; Filnarine; GNO; Graten; Infumorph; Kadian; Kapabloc; Kapanol; LA Morph; Loceptin; Longphine; M-Beta; M-Dolor; M-Eslon; M-Long; M-Retard; M-Stada; Malfin; Maxidon; MCR; Meconium; Meslon; Micro-Morphine; MIR; Mogetic; Morapid; Moraxen; Morcap; Moretal; Morficontin; Morfin; Morfina; Morin; Morph; Morphanton; Morphex; Morphgesic; Morphin; Morphini; Morphinum; Morphiphar; Morphitec; Morphium; Morstel; MOS; Moscontin; Morstel; Mortificontin; MS Contin; MS Direct; MS Long; MS Mono; MS/L; MS/S; MSI; MSIR; MSP; MSR; MST Continus; MST Unicontinus; Mundidol; MXL; Neocalmans; Nepenthe; Noceptin; Novo-Morphine; Oblioser; Oglos; OMS Concentrate; Onkomorphin; Opitard; Opsalvina; Oramorph; Ordine; Painbreak; PMS-Morphine; Q-Med Morphine; RA Morph; Ratio-Morphine; Relimal; Relipain; Repriadol; Rescudose; RMS; Roxanol; S-Morphine; Sevre-Long; Sevredol; Skenan; Slo-Morph; Slovalgin; SRM-Rhotard; Statex; Stellaphine; Stellorphinad; Stellorphine; Substitol; Uni Mist; Vendal; Zomorph    
IndicationPainApproved    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Therapeutic ClassAnalgesics    
CAS NumberCAS 57-27-2
PubChem Compound IDCID 5288826.    
PubChem Substance IDSID 4681.    
SuperDrug ATC IDN02AA01;    
SuperDrug CAS ID000057272;    
TargetOpioid receptorAgonist[2][3]
Ref 1Morphine sulfate extended-release capsules for the treatment of chronic, moderate-to-severe pain. Expert Opin Pharmacother. 2008 Jun;9(9):1585-94. To Reference
Ref 2Differential inhibitory/stimulatory modulation of spinal CCK release by mu and delta opioid agonists, and selective blockade of mu-dependent inhibition by kappa receptor stimulation. Neurosci Lett. 1991 Apr 1;124(2):204-7. To Reference
Ref 3Nat Rev Drug Discov. 2003 Jan;2(1):38-51.Knockouts model the 100 best-selling drugs--will they model the next 100? To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543